Skip to main content

NIH Sets Aside $6M for Genomic Technology Development in FY 2007

NEW YORK, June 19 (GenomeWeb News) - the National Institutes of Health has set aside $6 million in funding for the 2007 fiscal year to support technology development related to The Cancer Genome Atlas pilot project that kicked off in late 2005.


The goal of the genomic technology is to "inspire and promote the development of highly innovative tools and new ways to interrogate genomic alterations in cancer, NIH said.


The emphasis is on new high-resolution, high-throughput technologies to detect alterations in the cancer genome, epigenome, or transcriptome, "including, but not limited to: changes in DNA segment copy numbers, translocations, loss of heterozygosity, epigenomic modifications, and aberrant gene expression profiles."


In a notice issued Friday, titled, "Selection of Funding Opportunities for the Technology Component of the Cancer Genome Atlas (TCGA) Project," NIH outlined three separate funding opportunities under the initiative:



The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.